false 0001047335 0001047335 2020-02-20 2020-02-20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 21, 2020 (February 20, 2020)

____________________________

 

NATIONAL HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

__________________________

 

 

Delaware

(State or other jurisdiction of incorporation)

001-13489

(Commission File Number)

52-2057472

(I.R.S. Employer Identification No.)

100 Vine Street

Murfreesboro, Tennessee

(Address of Principal Executive Offices)

 

 

37130

(Zip Code)

 

Registrant’s telephone number, including area code: (615) 890-2020

 

Not Applicable

(Former name or former address, if changed since last report)

__________________________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.01 par value

NHC

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

ITEM 2.02.     RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

National HealthCare Corporation (“NHC”) issued a press release on February 20, 2020 announcing its December 31, 2019 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.

 

 

ITEM 9.01.     FINANCIAL STATEMENTS AND EXHIBITS.

 

(d)     Exhibits.

 

Exhibit No.

Description of Exhibit

99.1

Copy of press release issued on February 20, 2020 by National HealthCare Corporation announcing December 31, 2019 earnings.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:     February 21, 2020

 

NATIONAL HEALTHCARE CORPORATION

 

By: /s/ Brian F. Kidd

Name: Brian F. Kidd

Title:   Senior VP/Controller

            Principal Accounting Officer